GlassScriptPhysician profile
Dana Kelley
NPI 1952834301
$452.03
in general payments reported to CMS, 2019-2025
15 companies · $9.39 in 2025
The $9.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.09 · 2022: $270 · 2023: $120 · 2024: $14.71 · 2025: $9.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $76.11 | 2021-2022 | |
| Gynesonics, INC. | $69.04 | 2022 | |
| Minerva Surgical, INC | $59.79 | 2023 | |
| Hologic Sales and Service, LLC | $52.44 | 2022-2023 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Coopersurgical, INC. | $40.40 | 2022-2023 | Paragard T 380a |
| Abbvie INC. | $21.26 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $19.75 | 2023 | Vivjoa |
| Organon LLC | $16.86 | 2022 | |
| Myovant Sciences INC. | $16.14 | 2022 | |
| Aspira Women'S Health INC | $15.97 | 2022 | |
| Avion Pharmaceuticals | $15.83 | 2022 | |
| Shield Therapeutics INC | $14.71 | 2024 | |
| Coloplast Corp | $12.52 | 2022 | |
| Therapeuticsmd, INC. | $11.82 | 2021 | |
| Mayne Pharma Commercial LLC | $9.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.